In vivo efficacy studies of novel quinazoline derivatives as irreversible dual EGFR/HER2 inhibitors, in lung cancer xenografts (NCI-H1975) mice models-Reference-Cited by-同舟云学术

In vivo efficacy studies of novel quinazoline derivatives as irreversible dual EGFR/HER2 inhibitors, in lung cancer xenografts (NCI-H1975) mice models

Published:2020-06 Issue: Volume:99 Page:103790
ISSN:0045-2068
Container-title:Bioorganic Chemistry
language:en
Short-container-title:Bioorganic Chemistry

Author:

Das Debasis,Xie Lingzhi,Wang Jingbing,Shi Jingli,Hong Jian

Funder

Gusu City Scientific Leadership Program

Jiangsu Province Social development program

China Pharmaceutical University

Publisher

Elsevier BV

Subject

Organic Chemistry,Drug Discovery,Molecular Biology,Biochemistry

Reference26 articles.

1. Cancer statistics, 2019;Siegel;CA Cancer J. Clin.,2019

2. Cancer statistics in China, 2015: cancer statistics in China, 2015;Chen;CA Cancer J. Clin.,2016

3. Lung cancer in India: current status and promising strategies;Parikh;South Asian J. Cancer,2016

4. 50 years of progress in the systemic therapy of non-small cell lung cancer;Wakelee;Am. Soc. Clin. Oncol. Educ. Book,2014

5. Untangling the ErbB signalling network;Yarden;Nat. Rev. Mol. Cell Biol.,2001

Cited by 19 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Discovery and efficacy study of an ALK inhibitor AMX6001 in anaplastic large cell lymphoma Karpas299 mice models;European Journal of Medicinal Chemistry Reports;2024-12

2. Unraveling the future: Innovative design strategies and emerging challenges in HER2-targeted tyrosine kinase inhibitors for cancer therapy;European Journal of Medicinal Chemistry;2024-10

3. In Silico Molecular Modeling of Four New Afatinib Derived Molecules Targeting the Inhibition of the Mutated Form of BCR-ABL T315I;Molecules;2024-09-08

4. Design of balanced dual-target inhibitors of EGFR and microtubule;Bioorganic Chemistry;2024-02

5. Discovery of Novel, Selective Prostaglandin EP4 Receptor Antagonists with Efficacy in Cancer Models;ACS Medicinal Chemistry Letters;2023-05-22